Prof. Kwan serves as the Senior Orthopaedic Consultant of the Spine Surgery, Department of Orthopaedic Surgery, University of Malaya, Kuala Lumpur, and the President of the Asia Pacific Spine Society (APSS) 2023/2025. He was the Past President of the Malaysia Spine Society (MSS) 2019/21. His practice is mainly devoted to spinal deformity, i.e., scoliosis patients.  He has vast experience in taking care of and treating scoliosis patients via non-operative management, as well as operative management. He operates an average of 300 spine cases a year, with approximately 200 cases of scoliosis cases.   Prof. Kwan is an active member of numerous international professional spine societies. He is well-known internationally, as well as in the regional spine community, where he currently serves as the President of the Asia Pacific Spine Society (APSS). He is also an Active Member of the Scoliosis Research Society (SRS) and AOSpine. He has published more than 100 articles in the International/National Scientific Peer-Reviewed Journals. He was awarded many prestigious MOA research awards, namely the ‘P. Balasubramaniam Award 2014 and 2015’ for the best basic sciences research published papers for 2 consecutive years. He was later awarded the “Subir Sengupta Award in 2017 and 2018” for the best clinical research published papers for another 2 consecutive years. Due to his vast academic contributions, he was appointed as a member of various editorial board members and reviewers for many notable journals.  He has written many academic books and videos related to orthopaedic and spinal surgery and has also contributed book chapters about spinal disorders. Due to his dedicated teaching, he was conferred the ‘Best Lecturer (Clinical) Award by the Faculty of Medicine, University of Malaya in the year 2013’.

Professor Dr. See Mee-Hoong Professor Dr. See Mee-Hoong is an esteemed senior lecturer at the University of Malaya and a dedicated Consultant Oncoplastic Breast Surgeon at the University Malaya Medical Center (UMMC). Graduating with her undergraduate medical degree from UPM in 2003, she continued her academic excellence by earning her Master's Degree in Surgery (General Surgery) from the University of Malaya in May 2011 and obtained her fellowship in Breast Oncoplastic training from 2012 to 2015 in Universiti Malaya and Mahidol University, Thailand. Currently, she is nationally registered as a Breast Oncoplastic Surgeon. Her commitment to medical education and clinical practice led her to join the University Malaya Medical Faculty in 2012, where she specialized as a clinical lecturer focusing on Breast Oncoplastic Surgery. Dr. See further honed her skills as an honorary fellow at Siriraj Hospital, Mahidol University, Bangkok, Thailand in 2013, and later completed advanced training in minimally invasive techniques and Cryoablation at Kameda Medical Centre under Dr. Eisuke Fukuma in 2016. In 2022, Dr. See underwent robotic breast surgery training at Chang Hua Christian Medical Centre, Taichung, Taiwan. She has since pioneered minimally invasive breast surgeries at UMMC, offering patients the benefits of early recovery, smaller scars, better aesthetic outcomes, and comparable oncological results. A pioneer in Malaysia, she introduced 2D and 3D endoscopic nipple-sparing mastectomy (NSM) as early as 2019 and pioneer the FIRST MALAYSIA Robotic NSM with immediate implant reconstruction in 2025 . She has also been elected as a council member of Breast Surgical International in 2024, marking significant milestones in her leadership and expertise. Dr. See serves as the clinical head of the Breast Surgery Unit at UMMC (currently known as the Breast and Endocrine Unit), where she leads a team committed to providing high-quality care to patients. Her research interests span Clinical Breast Surgical Oncology, including Oncoplastic Surgery, Minimally Invasive and Robotic Breast Surgery, Enhanced Recovery After Surgery (ERAS), and Intraoperative Radiotherapy (IORT). She has published over 70 scientific papers, led the development of Decision Aids in Breast Reconstruction, and is actively involved in multiple clinical trials, including the TARGIT-B trial. Dr. See is also actively engaged in advancing artificial intelligence (AI) in breast cancer diagnosis. She is currently collaborating with Kyungpook National University, Daegu, South Korea, on a clinical trial exploring AI applications for breast cancer diagnostics and treatment planning. A driving force in Dr. See's work is her passion for uniting Southeast Asian and Asian breast surgeons through knowledge sharing and collaboration. She spearheads this effort through the Asian Breast Surgery Forum (ABSF – an ECHO Project), which she leads in collaboration with the University of New Mexico’s Project ECHO®. The forum connects 12 Asian countries, fostering the exchange of expertise and best practices in breast surgery. Dr. See is actively involved in various international surgical organizations, including the International Oncoplastic Breast Surgery (IOPBS) and the International Endoscopic and Robotic Breast Surgery (IERBS) societies, contributing to the global advancement of breast surgical practices. Currently, Dr. See serves as the Deputy Head of the Visibility Unit in the Faculty of Medicine at the University of Malaya. Her leadership and vision continue to impact the field of breast surgery, both regionally and globally, as she remains dedicated to enhancing surgical standards, research, and patient outcomes.

Dr. Siti Idayu Hasan is a Senior Lecturer in the Family Health Discipline at the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya. After completing her PhD, she embarked on a significant journey as a Postdoctoral Research Fellow at UMCAS, collaborating with the International Tobacco Control project team in Canada. Her work focused on measuring the psychosocial and behavioral impact of key national-level policies under the WHO Framework Convention on Tobacco Control (FCTC). She is a Fellow of Hong Kong WHO Collaborating Centre (Tobacco Control) and Committee Member of Scientific Tobacco Working Group (WHO FCTC Malaysia). Continuing her career, Dr. Siti Idayu became the Impact Project Manager at UMCares. In this role, she led the development and management of frameworks to monitor, evaluate, and enhance the effectiveness of community-oriented projects. Her efforts have been pivotal in ensuring that these initiatives bring about meaningful and sustainable improvements in society. Dr. Siti Idayu’s current research themes include tobacco control, mental health, and impact evaluation. Her work in tobacco control encompasses projects like Smoking Cessation, Organizing, Planning, and Execution (SCOPE), Generational Endgame (GEG), and the International Tobacco Control (ITC) project. She is also deeply involved in mental health research, aiming to address and mitigate mental health issues within the community. Beyond her research, Dr. Siti Idayu consults in the expanding field of public health, with a particular focus on tobacco control and mental health. She enjoys engaging with the community through health promotion activities, such as the Generational Endgame initiative, conducted in various settings (i.e. workplace, school and public) to raise awareness and drive positive behavioral change. Dr. Siti Idayu's commitment to improving public health is unwavering. Her work is not just about research and academia; it’s about making a tangible difference in the lives of individuals and communities. She believes that through collaborative efforts and a deep-seated commitment to health promotion, we can create a healthier, more resilient future for everyone. Her journey inspires others to join in the mission of bettering our communities and making impactful contributions to public health.